| 
				全民健康保險藥品給付規定 / 健保碼及健保價 | 
		 
		
			| 
				See related Nexavar film-coated tab[蕾莎瓦 膜衣錠] information | 
		 
		
			| 
				  | 
		 
		
			| 
				製造商 | 
			
				Bayer Schering Pharma | 
		 
		
			| 
				代理/經銷商 | 
			
				Bayer Schering Pharma | 
		 
		
			| 
				成份 | 
			
				Sorafenib | 
		 
		
			| 
				適應症 | 
			
				Advanced renal cell carcinoma who have failed prior interferon-alpha- or interleukin-2-based therapy or are considered unsuitable for such therapy. Child-Pugh A class patients with hepatocellular carcinoma who are unable to undergo surgery & in whom local chemotherapy is unsuitable. | 
		 
		
			| 
				用量 | 
			
				Adult 400 mg bid. | 
		 
		
			| 
				用法 | 
			
				Should be taken on an empty stomach (Take on an empty stomach or w/ a low or moderate fat meal. If the patient intends to have a high fat meal, sorafenib should be taken on an empty stomach at least 1 hr before or 2 hr after meals. Swallow whole, do not chew/crush.). | 
		 
		
			| 
				美國食品藥物管理局之懷孕等級 | 
			
				
				Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant women may be acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious disease for which safer drugs cannot be used or are ineffective). | 
		 
		
			| 
				禁忌 | 
			
				Pregnancy & lactation. | 
		 
		
			| 
				注意事項 | 
			
				Dermatological toxicities. Monitor BP weekly during 1st 6 week of therapy & thereafter; severe or persistent HTN. GI perforation, hemorrhage, cardiac ischemia &/or infarction. Concomitant warfarin, irinotecan, doxorubicin therapy. | 
		 
		
			| 
				不良反應 | 
			
				Erythema, exfoliative dermatitis, acne, flushing, increased lipase, increased amylase, mucositis, stomatitis, dyspepsia, dysphagia. Hemorrhage, asthenia, pain, decreased appetite, influenza-like illness, pyrexia. Leukopenia, lymphopenia, anemia, neutropenia, thrombocytopenia. Hypophosphatemia, transient increases in transaminases. Arthralgia, myalgia. Depression. Impotence. Voice hoarseness. 
				View ADR Monitoring Website[參閱藥物不良反應監測表格] | 
		 
		
			| 
				交互作用 | 
			
				Warfarin, irinotecan, doxorubicin, substrates of CYP2B6 & CYP2C8, UGT1A1 & UGT1A9, rifampin, St. John's wort, phenytoin, carbamazepine, phenobarbital, dexamethasone. 
				View more drug interactions with Nexavar[蕾莎瓦] | 
		 
	
 
 
	
		
			| 
				本商品之市售規格 | 
		 
		
			
				
					
						
							| 
								劑型 | 
							
								包裝 | 
							
								圖片 | 
						 
						
							| 
								Nexavar 膜衣錠  | 
							
								
									
										
											| 
												Nexavar 200 mg x 60's | 
											
												  | 
										 
									
								 
							 | 
						 
					
				 
				 | 
		 
		
			
				
					
						
							
								
									
										
											| 
												Manufacturer: | 
											
												Bayer Schering Pharma | 
										 
										
											| 
												Distributor: | 
											
												Bayer Schering Pharma | 
										 
									
								 
							 | 
							
								  | 
							
								 
								 
								  | 
						 
					
				 
			 | 
		 
	
 
 |